Related Experiment Video
Updated: Sep 19, 2025
Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
Exploring the potential of honokiol as a treatment for cardiovascular disease (Review)
Yao Zeng1, Zishan Li2, Xiaolong Lin1
1Department of Pathology, The Affiliated Huizhou Hospital (Huizhou Third People's Hospital), Guangzhou Medical University, Huizhou, Guangdong 516001, P.R. China.
Insights
Honokiol, a natural compound, shows promise for treating cardiovascular diseases (CVDs) due to its anti-inflammatory and antioxidant effects. Further research is needed for its clinical application in managing heart conditions.
Area of Science:
- Pharmacology
- Cardiology
- Natural Products
Background:
- Cardiovascular diseases (CVDs) are a major global health concern, driving the need for novel therapeutics.
- Honokiol, a Magnolia-derived compound, exhibits beneficial pharmacological properties relevant to cardiovascular health.
Purpose of the Study:
- To review the bioactive properties of honokiol.
- To explore honokiol's cardiovascular effects and mechanisms of action.
- To assess the potential clinical utility of honokiol for CVD management.
Main Methods:
- Literature review of preclinical and clinical studies on honokiol and cardiovascular diseases.
- Analysis of honokiol's pharmacological actions, including anti-inflammatory, antioxidant, and vasodilatory effects.
- Evaluation of proposed mechanisms underlying honokiol's cardiovascular benefits.
Main Results:
- Honokiol demonstrates significant anti-inflammatory, antioxidant, and vasodilatory activities.
- Evidence suggests honokiol can positively impact various cardiovascular parameters.
- Multiple mechanisms, including modulation of signaling pathways, contribute to honokiol's cardioprotective effects.
Conclusions:
- Honokiol presents a promising therapeutic candidate for cardiovascular diseases.
- Further investigation into honokiol's efficacy and safety is warranted for clinical translation.
- Challenges and future research directions for honokiol in CVD treatment are outlined.
Abstract:
Cardiovascular diseases (CVDs) remain a leading cause of global mortality. As the burden of these diseases continues to rise, the development of innovative therapeutic agents has become increasingly important. Honokiol, a bioactive compound extracted from the bark and leaves of particular Magnolia species, has garnered attention for its wide-ranging pharmacological effects, including anti-inflammatory, antioxidant, and vasodilatory properties. Emerging research suggests that honokiol holds significant promise as a therapeutic agent for managing CVDs. The present review provides a comprehensive overview of the bioactive properties, cardiovascular effects, mechanisms of action, and potential clinical utility of honokiol for the treatment of CVDs. Furthermore, challenges and future directions for the clinical translation of honokiol are discussed at length to provide additional context.
Related Concept Videos
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
01:29Hypertension II: Pathophysiology
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:26Coronary Artery Disease II: Pathophysiology
01:20Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:26Coronary Artery Disease IV: Preventive Measures